ZA979868B - A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor - Google Patents

A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor

Info

Publication number
ZA979868B
ZA979868B ZA979868A ZA979868A ZA979868B ZA 979868 B ZA979868 B ZA 979868B ZA 979868 A ZA979868 A ZA 979868A ZA 979868 A ZA979868 A ZA 979868A ZA 979868 B ZA979868 B ZA 979868B
Authority
ZA
South Africa
Prior art keywords
aminondazol
buty
protease inhibitor
hiv protease
cyclic urea
Prior art date
Application number
ZA979868A
Inventor
James David Rodgers
Patrick Yuk-Sun Lam
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of ZA979868B publication Critical patent/ZA979868B/en

Links

ZA979868A 1996-11-08 1997-11-03 A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor ZA979868B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74710396A 1996-11-08 1996-11-08

Publications (1)

Publication Number Publication Date
ZA979868B true ZA979868B (en) 1999-05-03

Family

ID=25003668

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA979868A ZA979868B (en) 1996-11-08 1997-11-03 A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor

Country Status (5)

Country Link
AR (1) AR011275A1 (en)
HR (1) HRP970595A2 (en)
LT (1) LT4619B (en)
TW (1) TW383304B (en)
ZA (1) ZA979868B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
EP0765873B1 (en) 1991-10-11 2002-04-17 Dupont Pharmaceuticals Company Cyclic ureas and analogues useful as retroviral protease inhibitors

Also Published As

Publication number Publication date
TW383304B (en) 2000-03-01
HRP970595A2 (en) 1998-08-31
LT4619B (en) 2000-02-25
AR011275A1 (en) 2000-08-16
LT99045A (en) 1999-09-27

Similar Documents

Publication Publication Date Title
KR100190517B1 (en) Hiv protease inhibitors
IL131661A0 (en) Protease inhibitors
PL336589A1 (en) Serinic protease inhibitors
IL132088A0 (en) Protease inhibitors
IL132630A0 (en) Protease inhibitors
IL132629A0 (en) Protease inhibitors
EP0691345A3 (en) HIV protease inhibitor combinations
AUPM982594A0 (en) HIV protease inhibitors
EP1015438A4 (en) Protease inhibitors
ZA984514B (en) Hiv protease inhibitor
AU5310096A (en) Cyclic urea hiv protease inhibitors
ZA979868B (en) A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor
IL132998A0 (en) Vif-derived hiv protease inhibitors
GB9815925D0 (en) HIV Intergrase inhibitors
EE9900187A (en) 1- (3-Aminoindazol-5-yl) -3-butyl-cyclic urea useful as HIV protease inhibitor
EP0975612A4 (en) Protease inhibitors
ZA979867B (en) 1-(3-Aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
GB9714320D0 (en) Hiv protease inhibitor
HU0900220D0 (en) Hiv protease inhibitors
ZA982047B (en) Hiv protease inhibitors
SI0774969T1 (en) Hiv protease inhibitor combination
PH31405A (en) Hiv protease inhibitors.
SG49247A1 (en) Hiv protease inhibitors
AU4111896A (en) Hiv protease inhibitors
AU2480095A (en) HIV protease inhibitor combinations